SIREN : 377539051
MEDICOM INTERNATIONAL is a French company founded 36 years ago, specialized in the sector Édition de revues et périodiques. Based in DAMMARTIN-EN-GOELE (77230), this company of category PME shows in 2024 a revenue of 358 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 358 315 € | 366 028 € | 339 899 € | 75 019 € | 88 462 € | 286 126 € | 267 779 € | 197 179 € | 226 045 € |
| Net income | 6 525 € | 12 018 € | 4 354 € | 36 375 € | 510 € | 16 781 € | 5 564 € | -10 345 € | 4 392 € |
| EBITDA | 7 226 € | 12 582 € | 4 988 € | 36 566 € | 993 € | 16 780 € | 5 856 € | -10 199 € | 3 043 € |
| Net margin | 1.8% | 3.3% | 1.3% | 48.5% | 0.6% | 5.9% | 2.1% | -5.2% | 1.9% |
In 2024, MEDICOM INTERNATIONAL achieves revenue of 358 k€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.9%. Slight decline of -2% vs 2023. After deducting consumption (283 k€), gross margin stands at 76 k€, i.e. a rate of 21%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 7 k€, representing 2.0% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 7 k€, i.e. 1.8% of revenue. This profit can be retained or distributed to shareholders.
358 315 €
75 567 €
7 226 €
6 822 €
6 525 €
2.0%
The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.7 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 1.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
25.783%
36.904%
1.934%
3.734
9.8%
In 2024, the debt ratio of MEDICOM INTERNATIONAL (25.78) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of MEDICOM INTERNATIONAL (36.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of MEDICOM INTERNATIONAL (3.73) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 4579.65. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 2.7x. Financial charges are adequately covered by operations.
4579.648
2.74
In 2024, the liquidity ratio of MEDICOM INTERNATIONAL (4579.65) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of MEDICOM INTERNATIONAL (2.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. WCR is negative (-56 days): operations structurally generate cash. Notable WCR improvement over the period (-535%), freeing up cash.
-55 456 €
0 j
0 j
0 j
-56 j
Based on 67 transactions of similar company sales
(all years),
the value of MEDICOM INTERNATIONAL is estimated at
28 610 €
(range 15 643€ - 83 198€).
With an EBITDA of 7 226€, the sector multiple of 1.1x is applied.
The price/revenue ratio is 0.16x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 67 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MEDICOM INTERNATIONAL with other companies in the same sector:
Voir toutes les statistiques du secteur Édition de revues et périodiques
The revenue of MEDICOM INTERNATIONAL in 2024 is 358 k€.
Yes, MEDICOM INTERNATIONAL generated a net profit of 7 k€ in 2024.
The headquarters of MEDICOM INTERNATIONAL is located in DAMMARTIN-EN-GOELE (77230), in the department Seine-et-Marne.
The tax return of MEDICOM INTERNATIONAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MEDICOM INTERNATIONAL operates in the sector Édition de revues et périodiques (NAF code 58.14Z). See the 'Sector positioning' section above to compare the company with its competitors.